Interfering with Resistance to Smoothened Antagonists by Inhibition of the PI3K Pathway in Medulloblastoma

Author:

Buonamici Silvia1,Williams Juliet1,Morrissey Michael1,Wang Anlai1,Guo Ribo1,Vattay Anthony1,Hsiao Kathy1,Yuan Jing1,Green John1,Ospina Beatriz1,Yu Qunyan1,Ostrom Lance1,Fordjour Paul1,Anderson Dustin L.1,Monahan John E.1,Kelleher Joseph F.1,Peukert Stefan1,Pan Shifeng2,Wu Xu2,Maira Sauveur-Michel3,García-Echeverría Carlos3,Briggs Kimberly J.4,Watkins D. Neil5,Yao Yung-mae1,Lengauer Christoph1,Warmuth Markus1,Sellers William R.1,Dorsch Marion1

Affiliation:

1. Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA.

2. Genomics Institute of the Novartis Research Foundation, San Diego, CA 92121, USA.

3. Novartis Institutes for Biomedical Research, 4057 Basel, Switzerland.

4. Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21231, USA.

5. Monash Institute of Medical Research, Monash University, Clayton, Victoria 3168, Australia.

Abstract

Resistance of medulloblastoma to Smo antagonists can be delayed or prevented by specific drug combinations.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3